Finch Therapeutics Group

+$0.23 (+10.95%) Today
$0.00 (0.00%) As of 11:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FNCH and other ETFs, options, and stocks.

About FNCH

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms.

CEO
Mark Smith
Employees
189
Headquarters
Somerville, Massachusetts
Founded
2014

FNCH Key Statistics

Market cap
110.81M
Price-Earnings ratio
—
Dividend yield
—
Average volume
204.48K
High today
$2.32
Low today
$1.99
Open price
$2.06
Volume
75.63K
52 Week high
$22.10
52 Week low
$1.71

FNCH Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.52 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure